Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

The preparation method of rifapentine

A technology of rifapentine and rifaxazine, which is applied in the field of preparation of rifapentine, can solve the problems of increasing impurities and reducing yield, and achieves the effect of high impurity content, good stability and uniform particles

Active Publication Date: 2016-04-06
SICHUAN LONG MARCH PHARMA CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This method uses tetrahydrofuran as a solvent, because tetrahydrofuran is easy to oxidize, it is easy to oxidize the aldehyde group into a carboxyl group, which increases impurities and reduces the yield.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • The preparation method of rifapentine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] The present invention will be further described in detail through specific implementation examples below.

[0020] The embodiment of the present invention provides a preparation method of rifapentine, comprising the following steps:

[0021] A. Taking rifamycin S as the starting material, reacting with dimethylol terbumine in the first organic solvent and converting it into intermediate rifaxazine;

[0022] B. In the second organic solvent, adding a catalyst and a reducing agent to hydrolyze and open the intermediate rifaxazine;

[0023] C. The hydrolyzate of rifaoxazine is condensed into rifapentine solution with 1-amino-4-cyclopentylpiperazine;

[0024] D. Filtration of the rifapentine solution, segmental crystallization of multi-stage crystallization temperature, first separation, washing, second separation, drying, soaking, third separation, rinsing, spin-drying, sieving, drying , Mixing and refining process to get Rifapentine finished product.

[0025] Using rif...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of rifapentine, and the steps are as follows: rifamycin S is used as a starting material for reacting with dihydroxy methyl tert-butyl amine in a first organic solvent to convert into intermediate rifaoxazine; a catalyst and a reductant are added into a second organic solvent for hydrolysis ring opening of the intermediate rifaoxazine; a rifapentine solution is obtained by condensation of a rifaoxazine hydrolysis product and 1-amino-4-cyclopentyl piperazine; and a rifapentine finished product is obtained by filtration, segmented crystallization at multistage crystallization temperature, first separation, washing, second separation, drying, soaking, third separation, drip washing, spin drying, sieving, drying, and powder mixing refining processes of the rifapentine solution. The preparation method adopts the reductant which can play a role in anti oxidation; different crystallization temperature is adopted in the segmented crystallization process; and by combination with the adding of a crystallization solvent, the crystalline polymorph is uniform, the particles are uniform, the stability is good, and the defects of high impurity content and nonuniform particles of rifapentine processes in the prior art can be solved.

Description

technical field [0001] The invention relates to the field of medicines, in particular to a preparation method of rifapentine. Background technique [0002] According to the data and patent documents, at present, in the public drug synthesis database, the process route of rifapentine is as follows: 0.01ml of 3-formyl rifamycin SV is dissolved in tetrahydrofuran, and 0.011mol of rifamycin SV is added at room temperature 1-Amino-4-cyclopentylpiperazine. The reaction was followed by TLC until the starting material spot disappeared. The solvent was evaporated, and the residue was recrystallized from ethyl acetate to obtain rifapentine with a yield of 55% and a melting point of 179-180°C. This method uses tetrahydrofuran as a solvent, because tetrahydrofuran is easy to oxidize, it is easy to oxidize the aldehyde group into a carboxyl group, which increases impurities and reduces the yield. Contents of the invention [0003] The purpose of the present invention is to provide a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D498/08
CPCC07D498/08
Inventor 林学辉李建胡君
Owner SICHUAN LONG MARCH PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products